A secure platform for analyzing COVID-19 data
NCATS: SECURE PLATFORMS SUPPORT FOR THE N3C, NIDAP, AND ASPR
['FUNDING_OTHER'] · PALANTIR TECHNOLOGIES, INC. · NIH-11221081
This study is all about using a big collection of health data from millions of people to help researchers learn more about COVID-19 and find better ways to treat it, all while keeping your personal information safe.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PALANTIR TECHNOLOGIES, INC. (nih funded) |
| Locations | 1 site (DENVER, UNITED STATES) |
| Trial ID | NIH-11221081 on ClinicalTrials.gov |
What this research studies
This research focuses on the National COVID-19 Cohort Collaborative (N3C), which operates a large data enclave designed to support COVID-19 research. The N3C collects and harmonizes clinical data from over 60 contributors, encompassing more than 6.8 million individuals and 2.2 million COVID cases. By utilizing a secure cloud-based environment, the project ensures that sensitive information is protected while allowing researchers to analyze vast amounts of clinical data to improve understanding and treatment of COVID-19. The platform facilitates collaboration among various NIH institutes and federal agencies to enhance data-driven insights.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been diagnosed with COVID-19 or are part of the broader population affected by the pandemic.
Not a fit: Patients who have not been diagnosed with COVID-19 or are not involved in related clinical research may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and public health responses to COVID-19.
How similar studies have performed: Other research initiatives utilizing large-scale data aggregation and analysis have shown success in improving patient outcomes and understanding of diseases, indicating a promising approach.
Where this research is happening
DENVER, UNITED STATES
- PALANTIR TECHNOLOGIES, INC. — DENVER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZAVERTNIK, BRIAN — PALANTIR TECHNOLOGIES, INC.
- Study coordinator: ZAVERTNIK, BRIAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Coronavirus Infectious Disease 2019